Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-672,916
Closed -$52.3M 126
2021
Q2
$52.3M Sell
672,916
-301,918
-31% -$22.5M 0.61% 57
2021
Q1
$71.7M Sell
974,834
-259,071
-21% -$19.1M 0.85% 38
2020
Q4
$96.3M Sell
1,233,905
-11,316
-0.9% -$865K 1.17% 26
2020
Q3
$98.6M Buy
1,245,221
+36,361
+3% +$2.85M 1.33% 27
2020
Q2
$89.2M Buy
1,208,860
+629,582
+109% +$47.4M 1.3% 27
2020
Q1
$42.5M Buy
579,278
+30,467
+6% +$2.39M 0.72% 46
2019
Q4
$47.6M Sell
548,811
-8,973
-2% -$737K 0.62% 55
2019
Q3
$44.8M Sell
557,784
-65,853
-11% -$5.28M 0.62% 57
2019
Q2
$49.9M Buy
623,637
+7,870
+1% +$603K 0.61% 61
2019
Q1
$48.8M Buy
615,767
+33,693
+6% +$2.52M 0.62% 61
2018
Q4
$42.4M Buy
582,074
+3,393
+0.6% +$240K 0.62% 61
2018
Q3
$39.2M Buy
578,681
+549
+0.1% +$35K 0.49% 75
2018
Q2
$33.5M Buy
578,132
+207,924
+56% +$11.7M 0.44% 77
2018
Q1
$19.2M Buy
370,208
+24,422
+7% +$1.32M 0.26% 98
2017
Q4
$18.6M Sell
345,786
-52,955
-13% -$2.94M 0.25% 102
2017
Q3
$24.4M Buy
398,741
+107,210
+37% +$6.5M 0.31% 98
2017
Q2
$17.8M Buy
+291,531
New +$17.7M 0.23% 111

Other funds holding MRK

Capital Bank & Trust's MRK Position: Q3 2021 in Review

Capital Bank & Trust sold out of Merck (MRK) in Q3 2021, closing a stake of 672,916 shares — an estimated $52.3M sold.

Capital Bank & Trust first reported a position in MRK in Q2 2017 and held it in 17 quarters. The position peaked at $98.6M in Q3 2020. 2,647 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • Capital Bank & Trust reported no remaining Merck position as of Q3 2021 after selling out during the quarter.
  • Capital Bank & Trust sold 672,916 Merck shares in Q3 2021, an estimated $52.3M.
  • Capital Bank & Trust first reported a position in Merck in Q2 2017 and held it in 17 quarters.
  • Capital Bank & Trust's Merck position peaked at $98.6M in Q3 2020.
  • 2,647 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on Capital Bank & Trust's 13F filing for Q3 2021, filed 15 Nov 2021.